Arista's feasibility study service is for customers who wish to develop a specific assay. Feasibility studies are ideal for development of new assays, customization of existing assays or outsourcing the development work for proprietary antigens or antibodies. This type of study is a simple and cost effective way to determine if available reagents are capable of being developed into a working lateral flow assay. With Arista Biological's extensive experience developing all types of lateral flow assays, and industry standard manufacturing equipment, working with Arista combines great potential for a successful development with a high level of transferability. Feasibility studies can be performed in as little as two weeks. Reagents can be either supplied by the customer or sourced by Arista Biologicals Inc. Feasibility studies are billed 50% in advance and 50% following the successful completion of the assay.